Influenza vaccines: Evaluation of the safety profile.

about

Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults.100 years since the 1918 influenza pandemic

P2860

Q50420352-DC746A98-2644-4362-806D-9468B9EF6D96 Q57094837-3F650129-2AF7-4153-A363-6BD82C890E7F

P2860

Influenza vaccines: Evaluation of the safety profile.

Item

http://www.wikidata.org/entity/Q49345779

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Influenza vaccines: Evaluation of the safety profile.

@en

Influenza vaccines: Evaluation of the safety profile.

@nl

type

Item

label

Influenza vaccines: Evaluation of the safety profile.

@en

Influenza vaccines: Evaluation of the safety profile.

@nl

prefLabel

Influenza vaccines: Evaluation of the safety profile.

@en

Influenza vaccines: Evaluation of the safety profile.

@nl

P1476

Influenza vaccines: Evaluation of the safety profile.

@en

P2093

Claudia Maria Trombetta

http://www.w3.org/2001/XMLSchema#string

Elena Gianchecchi

http://www.w3.org/2001/XMLSchema#string

Emanuele Montomoli

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Vaccinology in the third millennium: scientific and social challenges

Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials

The Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy

The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

P304

657-670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/21645515.2017.1423153

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29297746

http://www.w3.org/2001/XMLSchema#string

P932

5861790

http://www.w3.org/2001/XMLSchema#string

Influenza vaccines: Evaluation of the safety profile.

about

P2860

P2860

Influenza vaccines: Evaluation of the safety profile.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P577

P698

P932